Acebrophylline PCD Pharma Franchise Company
Cafoli Lifecare manufactures and supplies 14 Acebrophylline formulations — under the Abrostep and Mucipoly brand families — for pharma distributors, medical agencies, stockists, and PCD franchise partners across India. The range spans plain tablets and capsules, a pediatric syrup, and high-demand combinations with Montelukast, Acetylcysteine, Desloratadine, and Bilastine.
What is Acebrophylline?
Acebrophylline is an airway mucoregulator and anti-inflammatory agent — a salt combining ambroxol with theophylline-7-acetic acid. It reduces mucus viscosity, improves mucociliary clearance, and relieves bronchial obstruction, which makes it a widely prescribed molecule for COPD, bronchial asthma, and acute or chronic bronchitis (PubChem, NCBI).
Our Acebrophylline Product Range
| Brand | Composition | Packing | MRP |
|---|
| Abrostep 100 Capsule |
Acebrophylline 100mg |
10×10 Alu Alu |
₹120 |
| Abrostep 200 Tablet |
Acebrophylline 200mg SR |
10×10 Alu Alu |
₹214 |
| Abrostep Syrup |
Acebrophylline 50mg |
Bottle |
On request |
| Abrostep M Tablet |
Acebrophylline 200mg + Montelukast 10mg |
10×10 Alu Alu |
On request |
| Abrostep NM Tablet |
Acebrophylline 100mg + N-Acetylcysteine 600mg + Montelukast 10mg |
10×10 Alu Alu |
On request |
| Abrostep DM Tablet |
Acebrophylline 200mg + Desloratadine 5mg + Montelukast 10mg |
10×10 Alu Alu |
₹280 |
| Abrostep MB Tablet |
Acebrophylline 200mg + Montelukast 10mg + Bilastine 20mg |
10×10 Alu Alu |
On request |
| Mucipoly A Tablet |
Acebrophylline 100mg + Acetylcysteine 600mg |
10×15 Alu Alu |
₹337 |
Plus more Acebrophylline formulations — select any product above to view specifications and request pricing.
Dosage Forms Available
Tablets (plain and sustained release), Capsules, and Syrup — covering adult and pediatric respiratory practice.
Therapeutic Applications
Acebrophylline products are marketed for COPD and chronic bronchitis management, bronchial asthma (especially combinations with Montelukast for allergic components), and productive cough with thick secretions. Prescriber base: pulmonologists, chest physicians, ENT specialists, general physicians, and pediatricians (syrup).
Why Acebrophylline is a High-Potential Molecule for Distributors
Rising pollution-linked respiratory illness keeps mucoregulator demand strong across India, and Acebrophylline’s combination flexibility — with Montelukast, antihistamines, and NAC — lets one molecule serve multiple prescription patterns. Repeat prescriptions in chronic respiratory disease give distributors dependable monthly rotation.
Why Choose Cafoli Lifecare
Monopoly rights based franchise model, WHO-GMP manufacturing, DCGI-approved portfolio, promotional inputs (visual aids, MR bags, product cards), fast dispatch, and competitive net rates — trusted by 1000+ franchise partners across India.
References
- NCBI PubChem — Acebrophylline Compound Summary
- PubMed (U.S. National Library of Medicine) — Published research on Acebrophylline
Our formulations of Acebrophylline find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: